Medicine and Dentistry
Ceftazidime
100%
Serum
66%
Respiratory Tract Infection
66%
Sputum
66%
Pneumonia
66%
Ceftizoxime
66%
Cefmetazole
66%
Antibacterial Activity
66%
Patient
66%
Side Effect
66%
Infection
33%
Escherichia coli
33%
Intravenous Drug Administration
33%
Infusion
33%
Gentamicin
33%
Exanthem
33%
Bronchiectasis
33%
Chronic Bronchitis
33%
Lung Tuberculosis
33%
Cefsulodin
33%
Cefoperazone
33%
Life
33%
Species
33%
Laboratory
33%
Leukocyte
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ceftazidime
100%
Respiratory Tract Infection
66%
Pneumonia
66%
Cefmetazole
66%
Ceftizoxime
66%
Gram Negative Bacterium
33%
Pseudomonas aeruginosa
33%
Escherichia coli
33%
Gentamicin
33%
Lung Tuberculosis
33%
Bronchiectasis
33%
Chronic Bronchitis
33%
Cephalosporin
33%
Rash
33%
Cefoperazone
33%
Infection
33%
Cefsulodin
33%
Mirabilis
33%
Biochemistry, Genetics and Molecular Biology
Clinical Study
100%
Ceftazidime
66%
Ceftizoxime
66%
Escherichia coli
33%
Blood Level
33%
Minimum Inhibitory Concentration
33%
Pseudomonas aeruginosa
33%
Antibacterial Activity
33%
Life
33%
Gram Negative Bacterium
33%
Gentamicin
33%
Leukocyte Count
33%
Mirabilis
33%
Species
33%
Time
33%
Dose
33%
Immunology and Microbiology
Sputum
66%
Staphylococcus aureus
66%
Escherichia coli
33%
Gram-Negative Bacteria
33%
Minimum Inhibitory Concentration
33%
Blood Level
33%
Leukocyte Count
33%
Antibacterial Activity
33%
Mirabilis
33%
Species
33%
Dose
33%
Time
33%
Life
33%